Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Page 213

Crux lucks out in $20m series B

Goldman Sachs and Citi have returned to back a $20m series B round for Crux Informatics that almost doubled its overall funding to $41m.

Oct 26, 2018

Cethik buys into NextVPU’s series A vision

The China Electronics Technology Group subsidiary has invested $28.7m in NextVPU, which will use the funds for R&D, recruitment and the pursuit of its growth strategy.

Oct 25, 2018

Investors pump $20m into Gauss

Gauss Surgical has received series C funding from SoftBank and eight healthcare providers including Northwell Health, OSF Healthcare and Providence Healthcare.

Oct 25, 2018

Investors pump $20m into Gauss

Stanford-StartX Fund's portfolio company Gauss Surgical has received series C funding from SoftBank and eight healthcare providers.

Oct 25, 2018

Qpex cues up $33m series A

Qpex Biopharma, which was spun off to develop The Medicines Company's anti-infective drug assets, has received $33m in its series A round.

Oct 24, 2018

Silk spins $30m from series B

The natural chemistry developer has increased its funding to $50m altogether, in a Kraft Group-backed round that will support an expansion into the textile industry.

Oct 24, 2018

Unifonic tunes into $21m series A

The Saudi Telecom-anchored STV led the round, while Raed Ventures also invested in cloud communications technology provider Unifonic.

Oct 23, 2018

Aledade adds $23m to latest round

GV-backed care manager Aledade has doubled the size of its latest funding round to $46m and increased its overall funding to $100m.

Oct 23, 2018

Unifonic tunes into $21m series A

The Saudi Telecom-anchored STV led the round, while Raed Ventures also invested in cloud communications technology provider Unifonic.

Oct 23, 2018

Qpex tackles $33m series A

Qpex has raised $33m in series A funding from Stanford University Draper Fund and others after spinning out of the Medicines Company to develop drugs targeting superbugs.

Oct 23, 2018
© 2025 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here